The aim of this health technology assessment (HTA) is to inform decision-making about the appropriate use of outpatient atrial fibrillation (AF) monitoring in patients who have experienced a stroke and/or transient ischemic attacks (TIA) . Policy issues such as determining the most appropriate device or sequence of devices for AF monitoring, identifying and selecting the appropriate patient population for ambulatory monitoring, and decisions on anticoagulant therapy initiation based on ambulatory monitoring results are in need of evidence-based support. This HTA will address these issues by evaluating the clinical effectiveness, and cost-effectiveness of AF ambulatory monitoring devices in outpatient stroke and/or TIA patients. This HTA will also identify patient perspectives regarding the value and impact of outpatient cardiac monitoring devices for AF monitoring on their health, health care, and quality of life.
Copyright © 2015 CADTH. This report may be reproduced for non-commercial purposes only and provided that appropriate credit is given to CADTH.